Stryker Corporation (NYSE:SYK)
February 12th, 2019
Amidst rising markets Stryker Corporation closed Tuesday up 1.07%, a $1.96 increase to close on $185.66. Furthermore it hit a new 52 week high of $185.81.
Stryker Corporation is listed on the S&P 500 index, and was one of 405 stocks that rose today. Weighted by market cap, SYK represents about 0.28% of the S&P 500.
Analysis results from 29 analysts points to the possibility that Stryker Corporation might rise somewhat (1.61%).
The market sectors were mixed Tuesday with a majority of the sectors trending up. Materials saw the biggest increase of the day (2.25%), while Real Estate saw the biggest drop (-0.70%). Industrials has seen the biggest year-to-date gain at 13.91%.
Materials saw the biggest turnaround from its 5-day performance of -1.14%, as it went up 2.25%. Real Estate saw a turn around from its 5-day performance of 0.96% trading down -0.70%.
- Materials went up with a 2.25% change.
- Consumer Discretionary went up with a 1.66% change.
- Industrials went up with a 1.56% change.
- Financials went up with a 1.56% change.
- Information Technology went up with a 1.36% change.
- Healthcare went up with a 1.34% change.
- Energy went up with a 1.18% change.
- Communication Services went up with a 1.14% change.
- Consumer Staples went up with a 0.88% change.
- Utilities went up with a 0.17% change.
- Real Estate went down with a -0.70% change.
Stryker Corporation Info
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned sales subsidiaries and branches, as well as third-party dealers and distributors in approximately 85 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
All amounts in USD unless otherwise indicated
Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.